Dynamic bTMB combined with residual ctDNA improves survival prediction in locally advanced NSCLC patients with chemoradiotherapy and consolidation immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dynamic bTMB combined with residual ctDNA improves survival prediction in locally advanced NSCLC patients with chemoradiotherapy and consolidation immunotherapy

Published:2024-06 Issue:2 Volume:4 Page:177-187
ISSN:2667-0054
Container-title:Journal of the National Cancer Center
language:en
Short-container-title:Journal of the National Cancer Center

Author:

Wang Yu,Wang Wenqing,Zhang Tao,Yang Yin,Wang Jianyang,Li Canjun,Xu Xin,Wu Yuqi,Jiang Ying,Duan Jinghao,Wang Luhua,Bi Nan

Funder

Chinese Academy of Medical Sciences & Peking Union Medical College

National Natural Science Foundation of China

Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences

Publisher

Elsevier BV

Reference46 articles.

1. Cancer treatment and survivorship statistics, 2022;Miller;CA Cancer J Clin,2022

2. Lung cancer incidence and mortality in China: updated statistics and an overview of temporal trends from 2000 to 2016;Zheng;J Natl Cancer Cent,2022

3. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Auperin;J Clin Oncol,2010

4. Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Spigel;J Clin Oncol,2022

5. Long-term results of NRG Oncology RTOG 0617: standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer;Bradley;J Clin Oncol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP